Clinical Trials
9 trialsNCT06744946 2024-12-20
Thoracoscopic Talc Pleurodesis Versus Bleomycin -Tranxemic Acid Mixture Injection in Chest Tube in Malignant Pleural Effusion
Alexandria University
Phase 4 Completed
NCT04792970 2023-09-28
Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
Duke University
Phase 4 Terminated
NCT05077111 2021-10-14
VATS
Ain Shams University
Phase 4 Unknown
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT02975921 2019-01-11
Betadine Pleurodesis Via Tunneled Pleural Catheters
Yale University
Phase 4 Withdrawn
NCT01670786 2014-05-13
Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion
Grupo de Pesquisa em Pleura e Oncologia Toracica
Phase 4 Completed
NCT00978939 2013-12-30
ASAP
Duke University
Phase 4 Completed
NCT00099541 2009-11-23
Non-small Cell Lung Cancer Registry
Novartis
Phase 4 Completed
NCT00789087 2008-11-11
Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion
University of Sao Paulo
Phase 4 Completed